Geron Corp (GERN)
3.56
-0.02
(-0.56%)
USD |
NASDAQ |
Apr 25, 16:00
3.57
+0.01
(+0.28%)
After-Hours: 20:00
Geron Price to Book Value: 7.840 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 7.840 |
| April 24, 2024 | 7.884 |
| April 23, 2024 | 7.708 |
| April 22, 2024 | 8.215 |
| April 19, 2024 | 8.126 |
| April 18, 2024 | 8.215 |
| April 17, 2024 | 8.104 |
| April 16, 2024 | 7.884 |
| April 15, 2024 | 7.598 |
| April 12, 2024 | 8.016 |
| April 11, 2024 | 8.303 |
| April 10, 2024 | 7.576 |
| April 09, 2024 | 7.554 |
| April 08, 2024 | 7.334 |
| April 05, 2024 | 7.312 |
| April 04, 2024 | 7.069 |
| April 03, 2024 | 7.069 |
| April 02, 2024 | 6.827 |
| April 01, 2024 | 6.981 |
| March 28, 2024 | 7.268 |
| March 27, 2024 | 7.290 |
| March 26, 2024 | 7.268 |
| March 25, 2024 | 7.180 |
| March 22, 2024 | 7.290 |
| March 21, 2024 | 7.334 |
| Date | Value |
|---|---|
| March 20, 2024 | 7.576 |
| March 19, 2024 | 7.180 |
| March 18, 2024 | 6.992 |
| March 15, 2024 | 7.400 |
| March 14, 2024 | 3.854 |
| March 13, 2024 | 3.854 |
| March 12, 2024 | 4.140 |
| March 11, 2024 | 4.713 |
| March 08, 2024 | 4.955 |
| March 07, 2024 | 4.625 |
| March 06, 2024 | 4.625 |
| March 05, 2024 | 4.603 |
| March 04, 2024 | 4.581 |
| March 01, 2024 | 4.977 |
| February 29, 2024 | 4.405 |
| February 28, 2024 | 4.294 |
| February 27, 2024 | 4.548 |
| February 26, 2024 | 4.559 |
| February 23, 2024 | 4.316 |
| February 22, 2024 | 4.329 |
| February 21, 2024 | 4.242 |
| February 20, 2024 | 4.286 |
| February 16, 2024 | 4.417 |
| February 15, 2024 | 4.593 |
| February 14, 2024 | 4.615 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.315
Minimum
Mar 18 2020
19.09
Maximum
Jan 24 2023
4.150
Average
2.854
Median
Mar 11 2021
Price to Book Value Benchmarks
| Madrigal Pharmaceuticals Inc | 9.542 |
| SELLAS Life Sciences Group Inc | -- |
| Johnson & Johnson | 5.144 |
| Immuneering Corp | 0.4682 |
| Moderna Inc | 2.934 |
Price to Book Value Related Metrics
| PS Ratio | 8511.30 |
| Price | 3.56 |
| Earnings Yield | -9.27% |
| Market Cap | 1.944B |